News

Kazakhstan, Russia, Ukraine to change drug reimbursement schemes

Published on 2013/09/16

Most of the Commonwealth of Independent States (CIS) countries do not have modern drug reimbursement policies. However, recently Kazakhstan, Russia and Ukraine have all taken steps to improve their dr...

2 views

Read more →

Biosimilars and US exclusivity

Published on 2013/09/13

Currently, the legal pathway in the US for the approval of biosimilars is the Biologics Price Competition and Innovation Act (BPCI Act) of 2009. The BPCI Act is part of the healthcare reform legislat...

4 views

Read more →

The biggest drug patent losses for 2013

Published on 2013/09/11

During 2012–2018 over US$290 billion of sales are at risk from patent expirations.  In fact, in 2013 alone patents will expire on drugs with yearly sales of US$29 billion. Generics are expected to ...

10 views

Read more →

Innovation in the generics industry

Published on 2013/09/09

The decrease in innovation in the originator pharmaceutical industry is leading to an increase in innovation in the generics pharmaceutical industry, according to new research. Innovation comes in ma...

6 views

Read more →

EU publishes consensus report on biosimilars

Published on 2013/09/06

The European Commission’s (EC’s) Enterprise and Industry Directorate-General has published a new report providing comprehensive information on the concept of biosimilars. The consensus informatio...

0 views

Read more →

Development of biosimilars for rheumatology

Published on 2013/09/04

In 2012, worldwide sales for the top three selling tumour necrosis factor (TNF) inhibitors reached US$20 billion. These biological treatments for arthritis are costing patients between US$10,000–US$...

3 views

Read more →

More UK patients affected by drug shortages in 2012

Published on 2013/09/02

The number of UK patients affected by shortages in brand-name medicines has increased during 2012, according to an online survey carried out by pharmacists’ organization Chemist+Druggist (C+D). A...

4 views

Read more →

Quality of generics in South Africa

Published on 2013/08/30

A study of the quality of generic medicines in South Africa has shown large differences in the perception and the actual quality of generics. The study was carried out in 73 patients and 15 private a...

3 views

Read more →

Research on clinical trial issues for biosimilars

Published on 2013/08/28

Period: September to December 2012 In order to demonstrate comparability between a biosimilar and its reference product, EMA recommends that the clinical trial should make it possible to detect a d...

3 views

Read more →

Patients in US turn to generics to save money

Published on 2013/08/26

According to a new report released on 9 April 2013 by the US Centers for Disease Control and Prevention, adults in the US used several strategies to reduce the costs of their medications, including as...

0 views

Read more →

Efficacy, extrapolation and interchangeability of biosimilars

Published on 2013/08/23

Biosimilars have been available in Europe for more than seven years; despite this fact, physicians still have concerns about the use of biosimilars. Some of their concerns have been discussed by membe...

3 views

Read more →

Cost savings from use of generic medicines in Ireland

Published on 2013/08/21

Ireland has one of the lowest usages of generics in the EU. However, in order to try to address this, the country introduced a new bill – Health (Pricing and Supply of Medical Goods) Bill 2012 – o...

0 views

Read more →